Earlier discovery of pregabalin's dependence potential might have been possible

European Journal of Clinical Pharmacology

Volumn 67, Issue 3, 2011, Pages 319-320

  Caster, Ola ^a   Edwards, I Ralph ^a   Norén, G Niklas ^a   Lindquist, Marie ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PREGABALIN;

ABNORMAL THINKING; AMNESIA; ANXIETY; APATHY; COGNITIVE DEFECT; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG SURVEILLANCE PROGRAM; DRUG TOLERANCE; EUPHORIA; HUMAN; INSOMNIA; LETTER; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL INSTABILITY; NERVOUSNESS; PERSONALITY DISORDER; PRIORITY JOURNAL; SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANALGESICS; DATABASES, FACTUAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 79954571298     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0920-4     Document Type: Letter

References (4)

1. Drug Enforcement Administration, Department of Justice 2005 Schedules of controlled substances: placement of pregabalin into schedule V Fed Regist 70 144 43633 43635
2. European Medicines Agency (EMA). Lyrica - Procedural steps taken after authorisation. Available from: www.ema.europa.eu/docs/en-GB/document-library/ EPAR-Procedural-steps-taken-and-scientific-information-after-authorisation/ human/000546/WC500046604.pdf. Accessed 26th August 2010.
3. S Schwan A Sundström E Stjernberg E Hallberg P Hallberg 2010 A signal for abuse potential for pregabalin - results from the Swedish spontaneous adverse reaction reporting system Eur J Clin Pharmacol 66 947 953 10.1007/s00228-010-0853-y 20563568
4. O Caster A Kindlundh-Högberg J Hopstadius GN Norén 2010 Early indicators of drug dependence Pharmacoepidem Dr S 19 S1 S224 S225